Multiple myeloma In Rwanda: The need for further research
Dr Testorri speaks with ecancer at EADO 2017 about using electrochemotherapy to improve cytotoxic uptake and promote tumour cell death.
He describes how electro-stimulation around tumours results in greater uptake of bleomycin, as standard, enabling local treatment of skin cancers without the need for possibly destructive surgery.
ecancer's filming has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.
Multiple myeloma In Rwanda: The need for further research
Addressing the rise of multiple myeloma in Rwanda
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Multiple myeloma in a resource constrained setting
Choosing Wisely in radiology Tanzania
Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours
Choosing Wisely to mitigate financial toxicity in cancer care in Africa
Plasma miR371 detects MRD and early relapse of germ cell tumours
The role of lymph nodes in stage 3 lung cancer